Paclitaxel, Anticancer agent
5
(1 Review)
|
(17 Publications)
- FuncS
PubMed
Functional Studies - Paclitaxel, Anticancer agent (AB120143)
E2 inhibits Paclitaxel induced androgen-independent prostate cancer cell death.
(A-D) 100 nM of E2 was added to the media of (A and B) LNCaP and (C and D) PC3 cells for 96h, followed by addition of Paclitaxel at the indicated concentrations for 24h. The cells were stained with Hoechst 33258 (5 μg/ml) to visualize nuclei and propidium iodide (PI) (0.2 μg/ml) to detect membrane damage (B and D). Cell death was quantified by scoring the number of PI positive cells relative to the total number cell nuclei in the same visual field (A and C). The values represent the mean ± S.E. of at least three independent experiments. * denotes p<0.05, ** denotes p<0.01, and *** denotes p<0.001.
E2 = 17-β-estradiol
(From Figure 1 of Dong et al).
Dong et al PLoS One. 2013; 8(12): e83519. Reproduced under the Creative Commons license http://creativecommons.org/licenses/by/4.0/
- Chemical Structure
Lab
Chemical Structure - Paclitaxel, Anticancer agent (AB120143)
2D chemical structure image of ab120143, Paclitaxel, Anticancer agent
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Publications (17)
Recent publications for all applications. Explore the full list and refine your search
Neoplasia (New York, N.Y.) 59:101092 PubMed39615107
2024
Applications
Unspecified application
Species
Unspecified reactive species
The EMBO journal 43:5288-5326 PubMed39261663
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of neurochemistry 168:100-114 PubMed38102893
2023
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 26:474 PubMed37664670
2023
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 13:351 PubMed36611083
2023
Applications
Unspecified application
Species
Unspecified reactive species
Molecules (Basel, Switzerland) 27: PubMed35566044
2022
Applications
Unspecified application
Species
Unspecified reactive species
Bioengineered 12:8419-8434 PubMed34661511
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cardiovascular toxicology 20:261-280 PubMed31571030
2019
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 9:4049 PubMed30282987
2018
Applications
Unspecified application
Species
Unspecified reactive species
Biomaterials 176:13-23 PubMed29852376
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com